Loader

Pathways

PathWhiz ID Pathway Meta Data

PW144670

Pw144670 View Pathway
drug action

Methoxsalen Drug Metabolism Action Pathway

Homo sapiens

PW176391

Pw176391 View Pathway
metabolic

Methoxsalen Predicted Metabolism Pathway

Homo sapiens
Metabolites of Methoxsalen are predicted with biotransformer.

PW132296

Pw132296 View Pathway
metabolic

Methoxyflurane Drug Metabolism

Homo sapiens
Methoxyflurane is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Methoxyflurane passes through the liver and is then excreted from the body mainly through the kidney.

PW145125

Pw145125 View Pathway
drug action

Methoxyflurane Drug Metabolism Action Pathway

Homo sapiens

PW146663

Pw146663 View Pathway
drug action

Methoxyphenamine Drug Metabolism Action Pathway

Homo sapiens

PW146348

Pw146348 View Pathway
drug action

Methscopolamine Drug Metabolism Action Pathway

Homo sapiens

PW127924

Pw127924 View Pathway
drug action

Methsuximide Action Pathway

Homo sapiens
Methsuximide is a succinimide anticonvulsant that increases the seizure threshold. Primarily used for childhood absence seizures. Functions by suppressing paroxysmal spike-and-wave patterns associated with lapses of consciousness in absence seizures. It can be found under the brand names Celontin and Petinutin. Used in the treatment of epilepsy. Methsuximide suppresses the paroxysmal three cycle per second spike and wave activity associated with lapses of consciousness which is common in absence (petit mal) seizures. The frequency of epileptiform attacks is reduced, apparently by depression of the motor cortex and elevation of the threshold of the central nervous system to convulsive stimuli. It binds to T-type voltage sensitive calcium channels. Voltage-sensitive calcium channels (VSCC) mediate the entry of calcium ions into excitable cells and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. The isoform alpha-1G gives rise to T-type calcium currents. T-type calcium channels belong to the "low-voltage activated (LVA)" group and are strongly blocked by mibefradil. A particularity of this type of channels is an opening at quite negative potentials and a voltage-dependent inactivation. GABA release is inhibited due to mutations of the SCN1A, SCN1B gene causing enhanced reuptake. Possible side effects of using methsuximide may include nausea, constipation, weight loss, and hiccups.

PW132480

Pw132480 View Pathway
metabolic

Methsuximide Drug Metabolism

Homo sapiens
Methsuximide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Methsuximide passes through the liver and is then excreted from the body mainly through the kidney.

PW145634

Pw145634 View Pathway
drug action

Methsuximide Drug Metabolism Action Pathway

Homo sapiens

PW000327

Pw000327 View Pathway
drug action

Methyclothiazide Action Pathway

Homo sapiens
Methyclothiazide (also known as Enduron or Methyclothiazid) is an organic compound that used for diuretic. It can inhibit the solute carrier family 12 member 3 (also known as sodium-chloride symporter) in the nephron to prevent water reabsorption. Solute carrier family 12 member 3 is also used for sodium reabsorption that count for 5% of total amount. Solute carrier family 12 member 3 transports chloride and sodium from lumen to epithelial cell, and sodium/potassium ATPases facilitate the export of sodium to basolateral interstitium to provide sodium gradient that will increase the osmolarity in interstitium, which lead to establishment of osmotic gradient for water reabsorption.